Study protocol for the Respond to Prevent Study: a multi-state randomized controlled trial to improve provision of naloxone, buprenorphine and nonprescription syringes in community pharmacies

Volume 43, Issue 1, 2022, Page 901-905 .

Source: Substance Abuse - February 25, 2022 Category: Addiction Authors: Traci C. GreenJeffrey BratbergAdriane N. IrwinJesse BoggisMary GrayGillian LeichtlingDerek BolivarAnthony FloydZain Al-JammaliJenny ArnoldRyan HansenDaniel Hartunga Opioid Policy Research Collaborative, The Heller School for Social Policy and Management, Source Type: research